MEDVi Alternative 2026: Top Physician-Supervised Options Worth Considering

MEDVi has built a following in the GLP-1 telehealth space, and for good reason. Their platform connects patients with licensed providers, handles prescriptions, and ships compounded medications. It works for a lot of people.

But not everyone. Maybe you have been waiting too long for provider responses. Maybe the pricing does not fit your budget anymore. Maybe you want more hands-on clinical oversight or access to peptide therapies beyond semaglutide. Whatever brought you here, you are not alone in looking for a MEDVi alternative in 2026.

We evaluated the leading telehealth GLP-1 programs across pricing, clinical care, medication options, and patient experience to help you find the right fit.

Why People Look for MEDVi Alternatives

MEDVi patients typically start exploring other options for a handful of recurring reasons:

• Limited provider interaction. Some patients feel the consultations are too brief or infrequent for the complexity of GLP-1 therapy.
• Pricing concerns. As patients titrate to higher doses, monthly costs can climb in ways they did not anticipate at enrollment.
• Narrow medication options. Patients interested in tirzepatide, BPC-157, or other peptide therapies may find MEDVi's formulary limiting.
• Customer service friction. Billing questions, shipping delays, and difficulty reaching support staff come up frequently in patient reviews.
• Desire for more personalized protocols. Cookie-cutter dosing schedules do not work for everyone, and some patients want a provider who adjusts based on their individual response.

None of these issues mean MEDVi is a bad program. They mean it is not the right program for everyone.

Top MEDVi Alternatives in 2026

1. Form Blends

Form Blends is a physician-supervised telehealth platform specializing in compounded GLP-1 and peptide therapy. What sets it apart from MEDVi is the depth of clinical engagement. Every patient works directly with a licensed physician who builds and adjusts their protocol based on individual response, lab work, and treatment goals.

The medication options are broader than most competitors. Beyond compounded semaglutide ($199/month) and tirzepatide ($249/month), Form Blends offers peptide therapies like BPC-157 for recovery and gut health. For patients who felt boxed in by MEDVi's formulary, that flexibility matters.

Pricing is transparent and all-inclusive. There are no hidden consult fees, no surprise charges at higher doses, and no long-term contracts.

Pros:

• Direct physician supervision with personalized dosing
• Broad formulary including GLP-1s and peptide therapies
• Transparent, flat-rate monthly pricing
• No long-term commitment required

Cons:

• Not the cheapest option available
• Newer brand with less mainstream recognition

2. Ro Body

Ro brings strong medical infrastructure to the GLP-1 space. Their in-house pharmacy and lab monitoring protocols give patients a clinical experience that goes beyond what most telehealth platforms provide. If your primary concern with MEDVi was the quality of medical oversight, Ro is worth evaluating.

Starting prices are competitive at $149/month for compounded semaglutide, though costs increase as you move to higher doses. The program is physician-led and data-driven, with dosing adjustments based on objective lab results rather than patient self-reporting alone.

Pros:

• Lab monitoring included in the program
• In-house pharmacy for quality control
• Strong medical oversight

Cons:

• Higher-dose pricing can add up
• Not available in every state
• No peptide therapy options

3. Henry Meds

If price is your primary reason for leaving MEDVi, Henry Meds deserves a look. At $149/month for compounded semaglutide with no separate consult fees, it is one of the most affordable physician-supervised GLP-1 programs available. The tradeoff is a more streamlined (some would say basic) clinical experience.

Pros:

• $149/month all-in pricing
• Simple enrollment process
• No hidden fees

Cons:

• Less personalized medical oversight
• No lab monitoring
• Limited medication options

4. Hims/Hers

Hims (and its sister brand Hers) operates at massive scale, which translates to reliable supply chains and a polished user experience. For patients who left MEDVi due to shipping delays or platform usability issues, Hims offers a smoother day-to-day experience. Clinical depth is not the strength here, but operational reliability is.

Pros:

• Well-established platform with reliable logistics
• Competitive pricing
• Strong mobile app experience

Cons:

• High-volume model means less individual attention
• Limited peptide options
• Provider interactions can feel transactional

5. SkinnyRx

SkinnyRx focuses specifically on weight loss medications and keeps its program lean. Pricing is competitive, the enrollment process is quick, and the platform does not try to be everything to everyone. If you want a focused GLP-1 program without the extras, SkinnyRx is a solid alternative.

Pros:

• Focused exclusively on weight loss
• Fast enrollment and shipping
• Competitive pricing

Cons:

• No peptide therapy options
• Less clinical depth than physician-supervised programs
• Smaller support team

MEDVi Alternatives Comparison Table

Program	Monthly Cost	Medications	Physician Supervision	Peptide Therapy	Contracts
Form Blends	$199+	Semaglutide, tirzepatide, peptides	Direct physician oversight	Yes	None
Ro Body	$149+	Semaglutide, tirzepatide	Lab-based monitoring	No	None
Henry Meds	$149	Semaglutide	Monthly check-ins	No	None
Hims/Hers	$149+	Semaglutide, tirzepatide	Provider consultations	No	None
SkinnyRx	$149+	Semaglutide	Basic oversight	No	None

Who Should Consider Switching from MEDVi

Switching GLP-1 providers mid-treatment is not something to do on a whim. If your current protocol is working and your side effects are manageable, stability has real value. But certain situations make a switch worth considering:

• You want more clinical involvement. If you feel like your MEDVi provider is not adjusting your protocol based on how you are actually responding, a program with deeper physician engagement (like Form Blends or Ro) may produce better outcomes.
• You need peptide therapy options. If you are interested in BPC-157 or other therapeutic peptides alongside your GLP-1, you will need a provider with a broader formulary.
• The cost is not sustainable. If your monthly spend has climbed beyond what you budgeted, programs like Henry Meds offer similar medication at lower price points.
• You are having service issues. Chronic shipping delays, billing errors, or difficulty reaching support are legitimate reasons to move your care elsewhere.

Frequently Asked Questions

Can I switch from MEDVi to another provider without a gap in treatment?

Yes, in most cases. The best approach is to enroll with your new provider before your current MEDVi prescription runs out. Most telehealth GLP-1 programs can get you started within a few days of your initial consultation, so there should be minimal or no gap in your medication.

Will I need to start over at a low dose if I switch providers?

Not necessarily. A good provider will review your treatment history and continue from your current dose if it is appropriate. Be prepared to share your dosing history and any relevant lab work with your new provider.

Are compounded GLP-1 medications the same across providers?

Compounded medications can vary by pharmacy. Different providers work with different 503B compounding pharmacies, and quality standards, formulations, and concentrations may differ. Programs that work with FDA-registered compounding facilities and maintain strong pharmacy relationships tend to deliver more consistent results.

Is it safe to switch GLP-1 providers?

Switching providers is safe as long as your new physician has a complete picture of your treatment history. The medication itself does not change; what changes is the clinical team managing your care. If anything, moving to a provider with better oversight can improve your safety profile.

Do I need to cancel MEDVi before signing up elsewhere?

You should cancel your MEDVi subscription to avoid being billed, but you do not need to cancel before enrolling with a new provider. Start the new program first, confirm your medication is on the way, and then cancel MEDVi to avoid a gap.

The Bottom Line

MEDVi works for many patients, but the GLP-1 telehealth market in 2026 offers enough strong alternatives that you do not have to settle for a program that is not meeting your needs. Whether you prioritize cost, clinical depth, or access to peptide therapies, there is a program built for what you are looking for.

Ready to explore a physician-supervised alternative? Form Blends offers personalized GLP-1 and peptide therapy with direct physician oversight, transparent pricing, and no long-term contracts. Start your consultation today.